Fundsmith Reduces $19M in Doximity, Inc. ($DOCS)

Key Points

  • Fundsmith changed its Doximity, Inc. ($DOCS) stake by 58.07% last quarter, cutting to 691,786 shares worth $13.86 million.
  • Wall Street's consensus rating on $DOCS is Hold and an average price target of $29.78.
  • $DOCS last traded around $20.04.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Fundsmith reduced its position in Doximity, Inc. ($DOCS) by 58.07% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 691,786 shares of Doximity, Inc. after selling 958,216 shares during the quarter. Fundsmith's holdings in Doximity, Inc. were worth $13.86 million as of its most recent filing.

Doximity, Inc. Stock Down 25.0%

Shares of Doximity, Inc. ($DOCS) traded around $20.04 on Saturday, down 25.0% for the day.

Last price$20.04
Market cap$4.76B
P/E ratio31.80
Forward P/E17.24
PEG ratio0.59
Beta1.21
52-week low$17.15
52-week high$76.51
50-day MA$22.80
200-day MA$29.32
Current ratio6.08
Quick ratio5.80
Debt-to-equity0.01

Doximity, Inc. Earnings

EPS (ttm)$0.84
Revenue (ttm)$655.57M
Revenue growth7.30%
Net margin25.48%
Return on equity17.21%
Next earningsNov 5, 2026

Analysts Set New Price Targets

ConsensusHold
Average target$29.78
High target$47
Low target$18
Analysts covering18

About Doximity, Inc.

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

ExchangeNYSE
SectorHealthcare
IndustryHealth Information Services
HeadquartersSan Francisco, CA
CEOMr. Jeffrey A. Tangney
Employees880

Get Doximity, Inc. alerts

New 13F filings, insider trades, and analyst moves on $DOCS, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.